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Abstract
 
Fas ligand, best known as a death-inducer, is also a costimulatory molecule required for maxi-
mal proliferation of mature antigen-specific CD4
 
 
 
 and CD8
 
 
 
 T cells. We now extend the role
of Fas ligand by showing that it can also influence thymocyte development. T cell maturation
in some, but not all, strains of TCR transgenic mice is severely impaired in thymocytes ex-
pressing mutant Fas ligand incapable of interacting with Fas. Mutant Fas ligand inhibits neither
negative selection nor death by neglect. Instead, it appears to modulate positive selection of
thymocytes expressing both class I– and class II–restricted T cell receptors of moderate affinity
for their positively selecting ligands. Fas ligand is therefore an inducer of death, a costimulator
of peripheral T cell activation, and an accessory molecule in positive selection.
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Introduction
 
T cell maturation is a carefully orchestrated process by which
multipotential cells are sequentially stripped of alternate fates
and primarily molded into self-tolerant CD4
 
 
 
, MHC class II
restricted helper T cells, or CD8
 
 
 
, MHC class I–restricted
cytolytic T cells (for reviews, see references 1 and 2). This
complex developmental pathway has been delineated in part
by the expression of molecules such as CD4, CD8, CD24
(heat stable antigen), preT
 
 
 
, and the TCR 
 
 
 
 and 
 
 
 
 chains.
Double negative (DN;
 
*
 
 CD4
 
 
 
CD8
 
 
 
) thymocytes include
the earliest T cell precursors, and can be further subdi-
vided on the basis of CD44 and CD25 expression into
DN1 (CD44
 
 
 
CD25
 
 
 
), DN2 (CD44
 
 
 
CD25
 
 
 
), DN3 (CD44
 
 
 
CD25
 
 
 
), and DN4 (CD44
 
 
 
CD25
 
 
 
) populations. These
give rise to TCR
 
low
 
 then TCR
 
hi
 
 double positive (DP)
CD4
 
 
 
CD8
 
 
 
 CD24
 
hi
 
 cells, that finally, after traversing transi-
tional CD4
 
 
 
CD8
 
low
 
 or CD4
 
low
 
CD8
 
 
 
 stages, mature into
CD24
 
low
 
 single positive (SP) CD4
 
 
 
 or CD8
 
 
 
 T cells (2).
Three distinct checkpoints – 
 
 
 
 selection, positive selec-
tion, and negative selection – ensure development of a T
cell repertoire that will best protect against invading patho-
gens while maintaining self-tolerance. 
 
 
 
 selection operates
through the pre-TCR (TCR 
 
 
 
 paired with preT
 
 
 
) and
checks that rearrangement has created a functional 
 
 
 
 chain
gene (3, 4). Success at this stage marks the cessation of rear-
rangement at the TCR
 
 
 
 locus and drives proliferation of
thymocytes and entry into the DP compartment. The
multi-step process of positive selection rescues thymocytes
from programmed cell death (death by neglect) through
signals generated when 
 
  
 
TCRs undergo an appropriate
interaction with self-MHC/peptide expressed on cortical
epithelial cells (for reviews, see references 1 and 2). Positive
selection results in CD4/CD8 lineage commitment, the
cessation of TCR
 
 
 
 gene rearrangement, and self-MHC re-
striction specificity. Negative selection results in the elimi-
nation of thymocytes with overt self-reactivity (for reviews,
see references 5 and 6).
While positive and negative selection hinge upon the
avidity of a particular TCR
 
  
 
 for self-MHC/peptide com-
plexes, additional cofactors impact these and other aspects
of thymocyte development. The CD8 and CD4 corecep-
tors clearly influence negative versus positive selection and
the acquisition of class I and class II restriction, and the
expression of desialylated CD8 molecules by thymocytes
increases class I binding affinity (for a review, see reference
7). CD30 and CD28 influence negative selection in vivo,
and an in vitro model has provided evidence that CD43
and CD5 both influence negative selection of a subpopula-
tion of thymocytes (for a review, see reference 6). The
modulation of positive selection by adhesion and costim-
ulatory molecules is still uncharted, although the appar-
ent requirement for sustained TCR signaling during this
checkpoint is compatible with their involvement (8).
One costimulatory molecule with the potential to influ-
ence thymic selection is Fas ligand (FasL), a member of the
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Abbreviations used in this paper:
 
 B6, C57BL/6; B6.
 
gld
 
, B6Smn.C3H-
 
Fasl
 
gld
 
; DN, double negative; DP, double positive; EAS, enzymatic ampli-
fication staining; MFI, mean fluorescence intensity; SP, single positive.T
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TNF superfamily. This molecule is not only capable of in-
ducing death through its receptor Fas (for reviews, see ref-
erences 9 and 10), but of enhancing the in vivo and in vitro
proliferative capacity of antigen-reactive peripheral T cells
(11, 12). As such, FasL is capable of bipolar signaling, deliv-
ering a death signal in one direction and a positive costimu-
latory signal in the other. Both CD4
 
 
 
 and CD8
 
 
 
 T cells are
susceptible to FasL-mediated costimulation (13), although
little is known about the nature of this costimulatory signal.
The thymus is one of the few organs in the body that co-
expresses Fas and FasL (14, 15), although whether these
molecules interact at this site has remained a mystery until
recently. This receptor/counter-receptor pair is not required
for negative selection of superantigen- or conventional anti-
gen-responsive thymocytes (16–18), except at high antigen
concentrations (19). We now show that FasL is required for
efficient differentiation of class I– and class II–restricted T
cells expressing TCRs with moderate affinities for self-
MHC/peptide. Thus, in addition to its other functions, FasL
acts as an accessory molecule in positive selection, presenting
a novel means for modulating this complex process.
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6), B6Smn.C3H-
 
Fasl
 
gld
 
 (B6.
 
gld
 
), B6.MRL-
 
Fas
 
lpr
 
 (B6.
 
lpr
 
), and B6.SJL-
 
Ptprc
 
a
 
 Pep3
 
b
 
/BoyJ (Ly5.1) (B6.Ly5.1)
mice were purchased from The Jackson Laboratory. TCR trans-
genic (Tg) mice, either generated or backcrossed 
 
 
 
10 genera-
tions onto a B6 background, include P14 (20), from The Jackson
Laboratory, and OT-1 (21), H-Y (22), AND (23), and TEa (24),
all bred at the University of Washington. TCR Tg mice were
maintained as heterozygotes by crossing TCR Tg with B6 mice
and screening PBLs for expression of V
 
 
 
5 (OT-1), V
 
 
 
2 (LCMV
and TEa), T3.70 (H-Y), or V
 
 
 
3 (AND) by flow cytometry.
FasL-deficient OT-1, LCMV, H-Y, AND, and TEa TCR Tg
mice were generated by cross/backcross breeding of TCR Tg
and B6.
 
gld
 
 mice and screening for the 
 
gld
 
 mutation as described
previously (12). Fas-deficient OT-1 mice (OT-1.
 
lpr
 
) were gener-
ated by cross/backcross breeding of OT-1 and B6.
 
lpr
 
 mice, and
screening for V
 
 
 
5 expression by flow cytometry and for the 
 
lpr
 
mutation by PCR (17). OT-1 and OT-1.
 
gld
 
 mice on the H-2
 
d
 
 or
H-2K
 
bm1
 
 backgrounds were obtained by cross/backcross breeding
of OT-1 and OT-1.
 
gld
 
 mice with Balb/cByJ mice (H-2
 
d
 
) or
B6C-H2
 
bm1
 
/By (H-2K
 
bm1
 
), both from The Jackson Laboratory,
and screening as above for TCR and 
 
gld
 
. Homozygosity for H-2
 
d
 
was assessed by screening PBLs for expression of H-2K
 
d
 
 and ab-
sence of H-2K
 
b
 
 by flow cytometry. Homozygosity for H-2K
 
bm1
 
was determined by a PCR protocol provided by K. Hogquist
(University of Minnesota, Minneapolis, MN). PCR using tail
DNA was performed (35 cycles; 1 min at 94
 
 
 
C, 1 min at 50
 
 
 
C,
and 1 min at 72
 
 
 
C) using the forward primer 5
 
 
 
-GCAGTACGC-
CTACGACGGCT and the reverse primer 5
 
 
 
-TTACTGAATT-
CTTCAGGTATCTGCGGAG. Reaction products were di-
gested with PstI and run on a 6% polyacrylamide gel to reveal a
single band of 190 bp for H-2K
 
b
 
 or two bands of 115 and 75 bp
for K
 
bm1
 
. AND and AND.
 
gld
 
 mice on an I-E
 
k
 
 background were
obtained by cross/backcross breeding of AND with C3H/HeJ or
with C3H/HeJ-
 
Fasl
 
gld
 
 mice (both from The Jackson Laboratory)
and screening for absence of V
 
 
 
3-deleting endogenous superanti-
gens and for V
 
 
 
3, I-E
 
k
 
, and I-A
 
b
 
 expression as above. Ly5.1 con-
genic OT-1 mice (OT-1.Ly5.1) were generated by cross/back-
cross breeding of OT-1 with B6.Ly5.1 mice and screening for
presence of V
 
 
 
5 and Ly5.1 and absence of Ly5.2 expression by
flow cytometry. All experiments were performed in compliance
with the University of Washington Institutional Animal Care and
Use Committee.
 
Flow Cytometry.
 
Single cell suspensions were prepared,
stained as described previously (12), and analyzed on a FAC-
Scan™ or FACSCalibur™ using CELLQuest software (Becton
Dickinson). Dead cells were excluded on the basis of forward and
side scatter profiles, and at least 10
 
5
 
 live-gated events were col-
lected from stained thymus samples. Monoclonal antibodies used
to stain cell surface molecules were: FITC-, PE- or allophycocy-
anin (APC)-labeled anti-CD4 (clone RM4–5), FITC- or biotin-
labeled anti-V
 
 
 
2 TCR (clone B20.2), FITC-labeled anti-
CD45.1 (clone A20), FITC-, PE-, or peridinin choloropyll-
 
 
 
protein (PerCP)-labeled anti-CD8
 
 
 
 (clone 53–6.7), PE-labeled
anti-V
 
 
 
3 TCR (clone KJ25), biotin-labeled anti-CD24 (clone
M1/69), anti-CD5 (clone 53–7.3), and anti-H-2K
 
d
 
 (clone SF1–
1.1), all from BD Biosciences, anti-H-Y TCR (clone T3.70,
provided by Dr. A. Farr, University of Washington), and Tri-
Color (TC)-labeled anti-CD8 (clone CT-CD8
 
 
 
; Caltag Labora-
tories). Biotin-labeled antibodies were detected with either
streptavidin-TC (Caltag) or streptavidin-APC (BD Biosciences).
Surface expression of FasL was detected using the enzymatic
amplification staining (EAS) Kit (Flow-Amp Systems) following
the manufacturer’s protocol. Thymocytes were incubated with
either biotinylated anti-FasL antibody (clone MFL3; BD Bio-
sciences) or biotinylated isotype control hamster IgG (clone A19–
3; BD Biosciences). During the streptavidin-FITC step, cells
were simultaneously stained to detect surface CD4 and CD8 ex-
pression. Markers showing the percentage of FasL
 
 
 
 cells were set
individually on the basis of isotype control staining for each thy-
mic subpopulation in each mouse strain. From 1–6% of isotype
control stained cells fell within the FasL
 
 
 
 marker.
 
Fas Ligand Expression by RT-PCR.
 
Single cell suspensions
were prepared from thymic lobes of B6 or OT-1 mice, stained
with anti-CD4 and anti-CD8 antibodies and sorted on a FACS-
Vantage™ cytometer (Becton Dickinson). Total RNA was puri-
fied and reverse transcribed using random hexamer primers and
AMV reverse transcriptase (Invitrogen). FasL PCR reactions
were performed using forward and reverse primers 5
 
 
 
-ATG-
CAGCAGCCCATGAATTAC and 5
 
 
 
-CCATATCTGTC-
CAGTAGTGC. PCR products were run on 1% agarose plus
0.5% Nusieve (FMC Bioproducts), transferred to GeneScreen
 
 
 
(NEN Life Science Products), and hybridized according to stan-
dard protocols. Membranes were probed with the end-labeled
oligonucleotide 5
 
 
 
-GTGGCTCTGGTTGGAATGGGA to de-
tect a fragment of 710 bp.
 
BM Chimeras.
 
BM chimeras were constructed as described
previously (25). Recipients were irradiated at 950 rads and recon-
stituted i.v. 
 
 
 
6 h later with 15 
 
 
 
 10
 
6
 
 T cell–depleted BM cells
(single BM chimeras) or a 1:1 mixture of 8 
 
 
 
 10
 
6
 
 cells of each do-
nor type (mixed BM chimeras). Recipients of mixed BM were
Ly5.1xLy5.2 F
 
1
 
, while donors were either Ly5.1 (OT-1) or Ly5.2
(OT-1.
 
gld
 
). Thymocytes were analyzed at various time points,
and host contribution to the thymocyte pool was negligible.
 
Results
 
Mutation in FasL Alters Thymocyte Maturation in OT-1
TCR Tg Mice.
 
To study the influence of FasL on T cell
maturation, we used mice bearing the 
 
gld
 
 point mutation,T
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encoding a variant of FasL that is incapable of binding Fas,
thereby abolishing both costimulator and death-inducer
functions of this bidirectional molecule (11, 26, 27). T cell
development was compared between wild type and 
 
gld
 
mice either Tg for the (ovalbumin 
 
 
 
 H-2Kb)-specific OT-1
TCR or expressing a polyclonal TCR repertoire. Fig. 1 A
shows notable differences in the CD4/CD8 profiles of
wild-type OT-1 (left) and OT-1.gld thymocytes (right).
Percentages of cells contained within each of the illustrated
gates are shown to the right of the dot plots. Most striking
is the reduction of CD8 SP thymocytes in OT-1.gld com-
pared with wild-type OT-1 mice. Both strains have similar
numbers and percentages of DN thymocytes, while DP
thymocytes are relatively overrepresented in OT-1.gld
mice. The reproducibility of these findings is illustrated in
Fig. 1 B (left panels). In agreement with previously pub-
lished work (16, 28, 29), similar analyses of B6 and B6.gld
mice expressing a diverse TCR repertoire (Fig. 1 B, right)
reveal no such differences. Total thymic cellularity is
roughly equivalent between OT-1 and OT-1.gld (see Fig.
4 B, right), and 2–3-fold lower than in B6 and B6.gld mice
(unpublished data).
In addition to skewed CD4/CD8 profiles, OT-1.gld
thymocytes also display deficient down-regulation of
CD24 and up-regulation of TCR expression, both corre-
lated with successful thymocyte maturation (Fig. 1 C).
Poor expression of the Tg TCR in OT-1.gld thymocytes is
not due to the coexpression of endogenous TCRs, as sim-
ilar staining patterns were seen using a pan-TCR antibody
(unpublished data). Thus, the absence of functional FasL is
associated with grossly defective T cell maturation in OT-1
mice, but not in congenic mice expressing a diverse T
cell repertoire. OT-1.gld mice do accumulate Tg TCR 
CD8  T cells in the periphery (unpublished data), which
may be driven by homeostatic regulation of peripheral T
cell niches.
It is likely that disruption of Fas–FasL interactions is
largely responsible for the defect in maturation experienced
by thymocytes expressing mutant FasL. T cell development
in Fas-deficient OT-1.lpr mice exhibits a pattern similar to
Figure 1. Defects in FasL alter thymocyte
maturation in OT-1 TCR Tg mice. (A)
CD4/CD8 profiles of thymocytes from
OT-1 (left) and OT-1.gld (middle) mice are
compared. Gates designated by letters in the
dot plots represent thymocyte subpopula-
tions described in the table (right), listing
percentages of thymocytes in each com-
partment. Bold numbers highlight major
differences observed. (B) Percentages of
thymocytes in the indicated subcompart-
ments are shown for individual animals. Left
panels: OT-1 (circles, n   8) are compared
with OT-1.gld (triangles, n   7) and OT-1.lpr
(diamonds, n   5) mice. Right panels: B6
(circles, n   4) are compared with B6.gld
mice (triangles, n   4). Means are desig-
nated by solid bars. Note changes in y-axis
scales for DP thymocytes. (C) V 2 (top)
and CD24 (bottom) expression in DP,
CD8 CD4dull (transitional cells along the
CD8 lineage), and CD8 SP thymocytes is
compared between OT-1 (open histograms,
thick lines) and OT-1.gld mice (light gray
histograms), and in CD8 SP thymocytes
between OT-1 and two OT-1.lpr mice
(rightmost panels). OT-1.lpr 1 (open histo-
grams) had 3.5% CD8 SP, while OT-1.lpr
2 (dark gray histograms) had 6.5% CD8 SP
remaining.T
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that seen in OT-1.gld mice (Fig. 1 B, left), although the ab-
normal representation within each subcompartment is less
severe in the former relative to the latter mice. Further-
more, thymocytes from OT-1.lpr mice with the most se-
verely depleted CD8 SP compartments tend to display the
most abnormal CD24 and TCR expression levels (Fig. 1
C, right, and unpublished data).
FasL Is Expressed by Both Wild-Type OT-1 and B6 Thy-
mocytes. To determine whether dysregulated FasL expres-
sion accounts for the differential influence of FasL defi-
ciency on thymocyte maturation in B6 versus OT-1 mice,
FasL expression in thymocyte subpopulations from these
two strains were compared at both the molecular and cellu-
lar levels. A semi-quantitative RT-PCR assay demonstrates
FasL expression in each thymocyte subpopulation, al-
though in some cases at low levels compared with positive
controls, without any appreciable difference between OT-1
and B6 mice (Fig. 2 A).
FasL protein on the cell surface was also revealed using
EAS, a flow cytometric technique for amplifying weak sur-
face expression (30). Fig. 2 B shows that FasL is expressed
on the surface of both B6 and OT-1 thymocytes, at levels
that vary with developmental stage (Fig. 2 B). At the DN
stage, 16–31% of B6 and 21–32% of OT-1 thymocytes are
FasL ; 7–14% of B6 and 20–29% of OT-1 DP thymocytes
express FasL surface protein. Beyond this stage, FasL ex-
pression diminishes in both strains. Although there is an in-
creased percentage of FasL  DP thymocytes in OT-1 rela-
tive to B6 mice, this is not universally correlated with
susceptibility to the influence of FasL on T cell develop-
ment (see below). Thus, expression of FasL at both the
RNA and surface protein levels suggests that the matura-
tional defects seen in OT-1.gld thymocytes are not the re-
sult of developmentally dysregulated FasL expression in
TCR Tg mice.
The Defect in OT-1.gld Thymocyte Development Is T Cell
Autonomous and Cannot Be Rescued by Neighboring Wild-Type
Thymocytes. To localize the influence of FasL on T cell
maturation to either the thymic epithelium or BM-
derived cells, radiation chimeras were constructed using
OT-1 or OT-1.gld BM donors and irradiated B6 or B6.gld
hosts. In each of the four types of chimeras analyzed at all
time points, the thymocyte subcompartment composition
was dependent upon the BM donor type. Representation
of donor CD8 SP thymocytes was diminished using OT-
1.gld BM, whether the host was of wild-type (Fig. 3 A,
open bars) or gld background (gray bars), compared with
that of wild-type OT-1 BM in either host (striped and
black bars). Therefore, FasL expression by BM-derived
cells dictates the pattern of thymocyte maturation, while
Figure 2. FasL RNA and surface protein are ex-
pressed by wild-type OT-1 and B6 thymocytes. (A)
RT-PCR was performed to assess FasL expression in
thymocytes from wild-type OT-1 and B6 mice sorted
on the basis of CD4 and CD8 expression, using gates
shown in Fig. 1 A. Testis was used as a FasL-positive
control. Stroma represents thymic capsule debris
treated with anti–Thy-1 plus complement to remove
contaminating thymocytes. Serial dilutions of cDNA
from each subpopulation were amplified in HPRT-
specific PCR reactions to titrate relative amounts of
cDNA. In FasL PCR reactions, equivalent amounts of
cDNA were amplified for testis, stroma, CD4 SP (B6
and OT-1), and DN (B6). 3-fold more cDNA was re-
quired for amplification of DN (OT-1), 6-fold for DP
(B6), 9-fold for DP (OT-1) and CD8 SP (OT-1), and
18-fold for CD8 SP (B6). FasL PCR products were
transferred to hybridization membranes and probed
with end-labeled oligonucleotide. (B) Thymocytes
from wild-type B6 (left panels) and OT-1 (right panels)
mice were stained for CD4 and CD8 by conventional
methods and for FasL by EAS. FasL expression (gray
histograms) is compared with isotype control (open
histograms) for gated DN, DP, CD8 SP, and CD4 SP
thymocytes. Numbers represent the percentage of
FasL  cells falling within the indicated markers.T
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FasL expression by radioresistant thymic epithelial cells
does not.
Mixed BM chimeras were generated to determine
whether BM-derived cells expressing wild-type FasL can
rescue the maturation of neighboring OT-1.gld thy-
mocytes. T cell–depleted BM cells from OT-1 and OT-
1.gld donors were mixed 1:1 and used to reconstitute irra-
diated B6 and B6.gld recipients. In each of three separate
experiments analyzed at three time points postreconstitu-
tion, maturation of wild-type OT-1 thymocytes failed to
correct the defective maturation of OT-1.gld T cells within
the same thymus (Fig. 3 B). Thus, T cells expressing mu-
tant FasL fail to mature properly, and their development
cannot be rescued in trans.
The OT-1.gld Defect in T Cell Maturation Does Not Result
from Defective Negative Selection or Death by Neglect. To test
whether FasL influences T cell maturation through cell
death by negative selection or lack of selection leading to
death by neglect, the distribution of thymocytes was
compared on wild-type and gld backgrounds in which
thymocytes expressing the OT-1 TCR are positively se-
lected (H-2Kb), negatively selected (H-2d), or not se-
lected (H-2Kbm1). The CD4/CD8 profiles of thymocytes
on the H-2d and H-2Kbm1 backgrounds are indistinguish-
able in OT-1 and OT-1.gld mice (Fig. 4 A). As expected
(31), OT-1 thymocytes on the H-2d and H-2Kbm1 back-
grounds are depleted for CD8 SP and enriched for DP
cells, as are OT-1.gld thymocytes on the H-2Kb back-
ground (Fig. 4 B). The total thymic cellularity in wild-
type mice is lower in the negatively selecting H-2d back-
ground and higher in the neutral H-2Kbm1 compared with
H-2Kb background, as previously shown (31). However,
their gld counterparts look no different, indicating that
there is no defect in negative or nonselection in the ab-
sence of functional FasL. In addition, on the negative-
selecting and neutral backgrounds, thymocytes from OT-1
and OT-1.gld mice express similar levels of both TCR
and CD24 (unpublished data).
FasL Can Also Influence the Maturation of Class II–restricted
T Cells. To examine whether the T cell maturational de-
fects in OT-1.gld mice can be generalized to other TCR
Tg lines, the class I–restricted H-Y and P14 TCR trans-
genes were bred onto the gld background, as were two class
II–restricted TCR transgenes, AND and TEa. T cell matu-
ration is unaffected by the gld mutation in H-Y and P14
TCR Tg mice (Fig. 5 A). However, FasL deficiency leads
to a decrease in the number of CD4 SP thymocytes and re-
duced thymic cellularity in cytochrome c–specific AND
TCR Tg H-2b mice (Fig. 5 B, left). Wild-type AND CD4
SP thymocytes also attain a more mature phenotype than
their  gld counterparts, as evidenced by up-regulation of
TCR and down-regulation of CD24 expression (Fig. 5 B,
right). Thus, FasL influences the size of the mature thy-
mocyte compartment in a class II–restricted TCR Tg
mouse strain. These differences were not seen when com-
paring TEa and TEa.gld mice (unpublished data), indicating
that this maturational defect is not universal for thymocytes
expressing all class II–restricted TCRs.
No correlation exists between FasL expression levels and
the degree to which FasL influences thymocyte maturation.
FasL expression by AND and P14 thymocytes is indistin-
guishable (Fig. 5 C), although thymocyte maturation in the
former strain is defective on the gld background, while the
latter is unaffected (Fig. 5, A and B). Thus, defects in thy-
mocyte maturation due to mutation in FasL cannot be solely
attributed to differences in FasL expression among the wild-
type TCR Tg lines. It may be significant that the fraction of
FasL  thymocytes in the H-Y TCR Tg line is substantially
lower than that in the other Tg strains (see Discussion).
Increasing the Strength of Positive Selection Bypasses the Influ-
ence of FasL on T Cell Maturation in AND Mice. To inves-
tigate whether the strength of signal delivered through the
TCR is an important variable in determining the contribu-
tion of FasL to T cell maturation, analyses were extended
to wild-type and gld AND TCR Tg mice carrying I-Ab or
I-Ek class II MHC molecules that mediate weaker and
Figure 3. The  defect in OT-1.gld t hy-
mocyte maturation is T cell autonomous
and cannot be rescued by neighboring wild-
type thymocytes. (A) Single BM chimeras
were analyzed 4, 6, and 8 wk after reconsti-
tution; only the latter two time points are
shown. Thymocytes were stained for CD4
and CD8 and mean percentages of donor
CD8 SP cells were calculated for each chi-
mera type (striped bars   OT-1 → B6;
black bars   OT-1 → B6.gld; open bars  
OT-1.gld → B6; gray bars   OT-1.gld →
B6.gld). Error bars represent the range of
two data points for each group. (B) Mixed
BM chimeras were analyzed at 4, 6, and 8
wk after reconstitution; results from week 8
are shown. Top panels: CD4/CD8 profiles
of thymocytes from the two different donor
types (OT-1 or OT-1.gld) within a single
B6 host. Bottom panels: CD4/CD8 profiles of thymocytes from the two different donor types (OT-1 or OT-1.gld) within a single B6.gld host. Dot plots
are gated on donor type using Ly5 allelic differences to distinguish donors from each other and the host. Percentages of CD8 SP thymocytes contained
within each donor component are shown. Data are representative of three experiments; n   2–4 for each group.T
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stronger positive selection for this TCR, respectively (32,
33). FasL expression on wild-type AND thymocytes on an
I-Ek background is similar to that on an I-Ab background
(Fig. 5 C). However, the level of CD5 expression is higher
in both DP TCRhi and CD4 SP TCRhi subsets from I-Ek
AND mice (Fig. 6 A). This up-regulation is expected,
given that CD5 expression levels on postselection thy-
mocytes reflect the intensity of signals delivered through
the TCR during selection (34), and indicates that the signal
delivered to the AND TCR is indeed stronger in I-Ek–
than in I-Ab–expressing mice.
Analyses of thymocyte subsets in AND and AND.gld
mice expressing I-Ab versus I-Ek reveal the impact of this
increase in signal strength. I-Ek not only delivers a stronger
positively selecting signal to thymocytes bearing the AND
TCR, it also mediates some negative selection, thereby
lowering thymus cellularity (reference 33; Fig. 6 B, left).
On a homozygous or heterozygous I-Ek background, thy-
mocytes from both AND and AND.gld mice develop nor-
mally (Fig. 6 B). Their TCR expression levels are identical
(Fig. 6 C) and their CD4/CD8 profiles (unpublished data)
and CD24 expression levels are similar to each other (Fig. 6
C) and to wild-type AND on the I-Ab background. Thus,
increasing the strength of the positive selection signal over-
rides the effect of FasL costimulation on the course of T
cell development.
Discussion
The FasL variant expressed by gld mice renders them sus-
ceptible to a peripheral lymphoproliferative disease caused
by the inability of mutant FasL to send death signals
through the Fas receptor (26, 27). Recent data from this
laboratory have demonstrated that mutant FasL is also inca-
pable of mediating a costimulatory signal that drives maxi-
mal proliferation in mature, antigen-reactive T cells (11–
13). We now demonstrate that mutations in FasL also
impact T cell development. Thymocytes from gld mice
carrying certain TCR transgenes display aberrant develop-
ment (Figs. 1 and 5). This developmental perturbation is
evidenced by a decrease in mature thymocytes and altered
expression of maturation markers such as the TCR and
CD24. While there are no gross alterations in thymocyte
maturation in B6.gld mice with a diverse TCR repertoire
(references 16, 28, and 29; Fig. 1 B), we have detected sub-
tle but reproducible maturational defects. The expression
levels of several, but not all, V  elements are depressed in
SP thymocytes of B6.gld mice compared with their wild-
type counterparts (unpublished data), mirroring the de-
crease in TCR expression levels seen in OT-1.gld and
AND.gld mice. Minor repertoire differences were also de-
tected, with a lower fraction of both CD4 and CD8 SP
thymocytes from B6.gld mice expressing V 3 (the   chain
of AND), and a slight overrepresentation of V 6  CD8 SP
in B6.gld relative to wild-type B6 mice. In addition, CD8
SP thymocytes expressing V 5 (the   chain of OT-1) are
underrepresented in B6.gld relative to wild-type mice (un-
published data), thus extending our findings beyond TCR
Tg mice.
It is possible that FasL on the surface of a BM-derived
cell binds Fas on an epithelial cell, thereby initiating posi-
tive signaling through Fas, signaling that has been demon-
strated in human T cells (35, 36). Such an interaction could
induce the secretion of a positive mediator, influencing
Figure 4. FasL deficiency does
not affect negative selection or
death by neglect. (A) Compari-
son between CD4/CD8 profiles
of thymocytes from OT-1 and
OT-1.gld mice on an H-2d (left
panels) or an H-2Kbm1 back-
ground (right panels). (B) OT-1
mice on an H-2Kb background
(left of each panel; OT-1 n   8,
OT-1.gld n   7) were compared
with those on an H-2d (middle
of each panel; OT-1 and OT-1.gld
n   4) and an H-2Kbm1 (right of
each panel; OT-1 and OT-1.gld
n     4) background. For each
strain, percentages of CD8 SP
(left panel), DP (middle panel),
and total thymocytes (right
panel) are shown for individual
OT-1 (circles) and OT-1.gld
mice (triangles). Means are des-
ignated by solid bars. Note change
in y-axis scale for H-2Kbm1 total
thymocytes.T
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thymocyte maturation. However, the fact that thymocytes
expressing wild-type FasL cannot rescue the maturation of
neighboring gld thymocytes, even those sharing the same
TCR (and thus recognizing the same ligands), renders this
explanation unlikely (Fig. 4 B). We instead favor the sim-
pler interpretation that Fas and/or some other molecule
expressed by BM-derived cells or thymic epithelial cells
binds to FasL on thymocytes and initiates delivery of a pos-
itive reverse signal through FasL. This interpretation is
consistent with our data, offers a unifying role for FasL in
thymocyte maturation and peripheral T cell activation (11–
13), and may also explain how Fas can influence T cell
maturation by a mechanism that does not involve cell death
pathways (37). It is interesting that thymocyte maturation
in OT-1.lpr mice is intermediate between that of OT-1
and OT-1.gld mice (Fig. 1, B and C). This attenuated phe-
notype may be due to the known leakiness in the lpr phe-
notype in the thymus (18) or the possible existence of an
alternate FasL binding partner (our unpublished data). Al-
though it is possible that the gld mutation is permissive for
the FasL function on stromal cells but not on thymocytes,
our data strongly suggest that the defect in thymocyte mat-
uration in OT-1.gld relative to OT-1 mice is T cell auton-
omous (Fig. 3) and likely results from abortive FasL inter-
actions with Fas (or an alternate partner), rather than
dysregulated FasL expression (Fig. 1, B and C, and Figs. 2
and 5 C).
Two of our observations do not fit well with the notion
that FasL delivers a positive signal that costimulates positive
selection. The total number and TCR expression levels of
thymocytes in AND.gld mice on an H-2b background are
unexpectedly similar to those in AND mice on an H-2k
background (Fig. 5 B, and Fig. 6, B and C). These data are
perhaps more consistent with a role for FasL as a negative
Figure 5. Maturation of thymocytes expressing
some, but not all, TCRs is influenced by FasL. (A)
Percentages of thymocyte subpopulations based on
CD4/CD8 expression were compared between
wild-type (circles) and gld H-2b mice (triangles) Tg
for the P14 TCR (left panel; wild-type and gld n  
4) and the H-Y TCR (right panel; wild-type n  
2, gld n   3). Means are designated by solid bars.
(B) Left: numbers of total and CD4 SP thymocytes
were compared between AND (circles; n   6) and
AND.gld (triangles; n   6) TCR Tg H-2b mice.
Means are designated by solid bars. Right: V 3
(top) and CD24 (bottom) expression were com-
pared between wild-type (open histograms) and gld
(gray histograms) CD4 SP thymocytes from AND
TCR Tg mice. (C) Thymocytes from wild-type
P14 (top row), H-Y (second row), and AND on
H-2b (third row), and H-2k backgrounds (bottom
row) mice were stained for CD4, CD8, and FasL as
in Fig. 2 B. FasL expression (gray histograms) is
compared with isotype control (open histograms)
for gated DN (left histograms) and DP (middle his-
tograms) thymocytes in all strains, CD8 SP in P14
and H-Y, and CD4 SP in AND (right histograms)
mice. Numbers represent the percentage of FasL 
cells falling within the indicated markers.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
356 Fas Ligand Influences T Cell Development
regulator of TCR signaling. According to this alternate
model, thymocytes from AND mice on an H-2b back-
ground that express mutant FasL might receive a stronger
signal than wild-type mice, and would display a mixed pos-
itively and negatively selected phenotype characteristic of
cells from AND mice on an H-2k background. Arguing
against this interpretation is the consistently lower number
of SP thymocytes in H-2b AND.gld mice relative to AND
and AND.gld mice on an H-2k background (10 relative to
21–24   106; Fig. 6 B) and the dissimilarity between the
TCR expression levels in total DP thymocytes from these
backgrounds (Fig. 7 A). While it is clear that the TCRhi
DP cells in mice on the H-2k background are depleted,
such is not the case in mice on the H-2b background.
Several additional predictions that follow from this alter-
nate model are not borne out experimentally. If FasL serves
as an attenuator of TCR signals, CD5 levels should be
higher in gld than in wild-type thymoctyes in all of the
TCR Tg strains. However, CD5 levels on DP thymocytes
from H-2b AND.gld are the same as wild-type, while CD5
levels on SP thymocytes from AND.gld are higher than on
wild-type (Fig. 7 B). The reverse is true for OT-1: CD5
expression levels are higher in OT-1.gld DP, but overlap-
ping with wild-type thymocytes at the SP stage (Fig. 7 B).
This model also predicts that CD5 levels on H-2b AND.gld
thymocytes should be similar to H-2k AND. However,
CD5 levels on the former cells are lower than on the latter
at all stages (Fig. 7 B). The absence of a consistent relation-
ship between CD5 levels and expression of mutant FasL
may suggest that while CD5 senses the strength of signal
through the TCR, it may not sense the modulation of that
signal by FasL or other accessory molecules. Finally, this
model would predict that maturation of the remaining SP
thymocytes should be efficient in all strains of mice. As
such, CD24 levels should be similar on thymocytes from
H-2b AND.gld and on H-2k AND thymocytes. However,
CD24 levels are highest for H-2b AND.gld, intermediate
for H-2k AND.gld, and lowest for AND on both H-2b and
H-2k backgrounds (with mean fluorescence intensities
[MFIs] of 296, 220, 198, and 192, respectively; Figs. 5 B
and 6 C). OT-1.gld SP thymocytes also display aberrantly
high CD24 expression compared with their wild-type
counterparts. We therefore favor a model invoking a role
for FasL as a positive modulator of thymocyte maturation as
most compatible both with the data described above and
with previous studies demonstrating a costimulatory role
for FasL in mature peripheral T cells (11–13).
Fas is expressed in the thymus by embryonic day 16.5
(14) and in adult DP and SP thymocytes (38–40). FasL
RNA is expressed at low levels in embryonic and adult
thymus (references 14, 15, 38, 39, and 41; Fig. 2 A) as well
as in stromal cells. In addition to FasL message, we have
also detected FasL surface expression by flow cytometry
(Figs. 2 B and 5 C) using a technique to enhance weak
staining obtained by conventional methods (30). Newly
synthesized FasL travels directly to secretory lysosomes in
mature T cells and undergoes targeted release upon vesicle
degranulation (42). Such a directional release of FasL could
explain why DP thymocytes do not commit suicide despite
their expression of Fas and their known susceptibility to
death mediated by anti-Fas antibodies and by FasL (39, 40).
SP thymocytes coexpressing Fas and FasL are not suscepti-
ble to Fas-mediated death (39), clearly indicating that addi-
tional control is exerted over this pathway, perhaps by ex-
pression of Fas splice variants lacking the death domain (43)
or decoy receptors for FasL that do not induce death (10).
What is the basis for the differential influence of FasL on
T cell maturation in polyclonal B6 mice and the various
lines of TCR Tg mice? Given that thymocyte maturation
defects are evident in TCR Tg mice, TCR locus accessi-
bility to the recombinase machinery is not an issue. Like-
wise, lineage commitment does not appear to be skewed by
the Fas/FasL interaction, because entry into both the ma-
ture CD4 and CD8 compartments is impaired by the gld
mutation (Figs. 1 and 5 B). Instead, this differential impact
is likely due to the nature of the TCRs expressed by the
developing thymocytes, as FasL expression levels in thy-
Figure 6. Increasing the strength of the positive selection signal by-
passes the need for FasL during thymocyte development. (A) CD5 ex-
pression is compared between wild-type AND TCR Tg mice on H-2b
(open histograms) and H-2k backgrounds (gray histograms). Histograms
represent DP V 3hi (left) or CD4 SP V 3hi thymocytes (right); mean
fluorescence intensity (MFI) for each is shown. (B) AND TCR Tg mice
on H-2b (wild-type and gld n   6), H-2b/H-2k heterozygous (wild-type
and gld n   4) and H-2k backgrounds (wild-type and gld n   4) were
compared. Numbers of total (left panel) and CD4 SP thymocytes (right
panel) are shown for AND (circles) and AND.gld (triangles). Means are
designated by solid bars. (C) V 3 (left) and CD24 (right) expression were
compared between wild-type (open histograms) and gld (gray histograms)
CD4 SP thymocytes from AND TCR Tg mice on an H-2k background.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
357 Boursalian and Fink
mocyte subpopulations are not correlated with defective
maturation in the absence of functional FasL (Figs. 2 and 5
C). Several possible explanations may account for why thy-
mocytes expressing only some TCRs are sensitive to FasL-
mediated signals.
FasL Encodes a Peptide that Interacts with Certain TCRs,
and This Peptide Is Altered by the gld Mutation. Defective T
cell maturation in OT-1.lpr mice and the fact that matu-
ration of both class I– and class II–restricted T cells is
enhanced by functional FasL renders this explanation un-
likely. Although an H-2Kb–binding peptide within wild-
type FasL is destroyed by the gld mutation (unpublished
data), this peptide does not appear to influence positive
selection when assayed in vitro for the ability to generate
DPdull from DPbright OT-1 thymocytes (S. Jameson and K.
Hogquist, personal communication).
Mutant FasL Is Incapable of Initiating Fas-mediated Death of
Negatively or Nonselected Thymocytes. Previous studies (16,
18) and the normal representation of thymocytes in B6.gld
mice weigh against this explanation for the defect in TCR
Tg gld mice. In addition, no reproducible differences in ei-
ther the uptake or loss of bromodeoxyuridine in OT-1.gld
relative to OT-1 or AND.gld relative to AND thymocytes
were apparent (unpublished data), indicating that move-
ment of AND.gld and OT-1.gld thymocytes into and out of
cellular subcompartments is not grossly disrupted. Thus,
cell cycle arrest of CD4 T cells (44) is an unlikely explana-
tion for our findings. Furthermore, crossing both wild-type
and  gld OT-1 TCR Tg mice onto negative-selecting
(H-2d) and nonselecting (Kbm1) backgrounds emphasizes that
mutant FasL does not influence thymocyte death either by
neglect or by negative selection (Fig. 4). Inhibition of death
pathways is therefore not the means by which mutant FasL
alters T cell maturation in a TCR-specific manner.
The Precise Timing of TCR Expression During Development
Dictates the Influence of FasL on Thymocyte Maturation.
TCR   transgenes are expressed early in the DN stage,
before rearrangement of the endogenous TCR  locus (45),
while asynchronous expression of first TCR  and then
TCR  is required for normal thymocyte maturation and
proliferation (46, 47). Although expression of the Tg TCR
is particularly early in the H-Y Tg line, OT-1, P14, and
AND Tg mice all show a similar pattern of TCR expres-
sion in the DN3 and DN4 compartments (unpublished
data). Thus, it is unlikely that FasL influences T cell matu-
ration in OT-1 and AND I-Ab TCR Tg mice because the
timing of TCR expression meets some requirement not
satisfied by the other transgenes.
The Avidity of Interaction Between the TCR and Its Positive-
ly Selecting Ligand Determines Whether FasL Costimulates Mat-
uration. FasL costimulation occurs in peripheral CD8  T
cells in conjunction with signals delivered through the
TCR, and this costimulation plays a greater role under
conditions of suboptimal activation (11). We speculate that
this notion of an upper and lower boundary also holds true
for FasL costimulation during thymocyte development.
According to this hypothesis (Fig. 7 C), the interaction be-
tween the P14 TCR and its positively selecting ligand is of
high enough avidity (34) to maintain sustained signaling for
successful positive selection, and although FasL is up-regu-
lated in thymocytes of these mice (Fig. 5 C), Fas/FasL in-
teractions become redundant at avidities of this strength.
Figure 7. FasL engagement likely enhances rather than
represses positive selection. (A) TCR expression levels
on total DP thymocytes from AND and AND.gld mice
on the H-2b background are dissimilar to those on the
H-2k background. V 3 expression is compared between
wild-type (open histograms) and gld (gray histograms)
AND mice on the H-2b (top panel) and H-2k back-
grounds (bottom panel). (B) CD5 levels on thymocyte
subpopulations do not correlate with expression of wild-
type FasL. CD5 expression is shown for DP TCRhi and
CD4 SP TCRhi thymocytes from wild-type (open histo-
grams, thick lines) and gld (gray histograms or open histo-
grams, dotted lines) AND mice on the H-2b (top panels)
and H-2k backgrounds (middle panels), and OT-1 mice
(bottom panels). MFI for each is shown. (C) Model de-
picting the correlation between thymocyte sensitivity to
FasL costimulation and avidity of the TCR for its select-
ing ligand. Thymocytes expressing TCRs of very low
avidity for selecting ligands die by neglect (left) while
those expressing TCRs with the highest avidity for se-
lecting ligands die by negative selection (right). Thy-
mocytes expressing TCRs with avidities between these
two extremes will be positively selected. Within this
range, thymocytes expressing TCRs with lower avidity,
such as H-Y, or those expressing TCRs with sufficiently
high avidity (P14 or AND selected on I-Ek) are not in-
fluenced by FasL costimulation during T cell develop-
ment. Thymocytes expressing TCRs with intermediate
avidity, such as OT-1 and AND selected on I-Ab, will
benefit from the costimulatory boost delivered by FasL to
develop into mature SP thymocytes (middle, gray area).T
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OT-1 (in a Kb environment) and AND on an I-Ab back-
ground fall within the boundaries that delineate the range
of avidities for which FasL costimulation is required for ef-
ficient positive selection, and T cell development in these
strains would, therefore, suffer in the absence of functional
FasL. The AND TCR on the I-Ek background increases
the efficiency of positive selection (32), and nudges this re-
ceptor out of the window of affinities sensitive to FasL co-
stimulation (Fig. 7 C). Thus, while FasL surface expression
is up-regulated in OT-1, P14, and AND TCR Tg mice on
both backgrounds, its relevance is not dictated solely by its
presence, but is also dependent on the avidity of the partic-
ular TCR for its selecting ligand. The comparison of AND
TCR Tg mice on the I-Ab versus the I-Ek background,
where maturation is induced by weak versus strong positive
selection signals delivered through the identical TCR, pro-
vides the strongest evidence in support of our model.
More speculative are the events that define the lower
boundary of FasL costimulation, beyond which lies the
maturation of thymocytes in H-Y TCR Tg mice. Several
explanations may account for the lack of influence of FasL
on the differentiation of thymocytes bearing such a TCR
with low avidity for its selecting ligand. It is possible that
H-Y thymocytes, while expressing TCRs capable of being
positively selected, receive a signal too weak to initiate the
entire program of events driving efficient differentiation, a
program which may involve the up-regulation and subse-
quent utilization of FasL. If FasL is never properly up-regu-
lated, its absence would not alter thymocyte maturation.
This notion is compatible both with the lower expression
of CD5 on postselection thymocytes and peripheral T cells
of H-Y mice compared with those from P14 (34) and OT-1
mice (our unpublished data), and with the low level of
FasL surface expression by H-Y Tg thymocytes relative to
the other TCR Tg lines (Fig. 5 C). The connection be-
tween up-regulation of FasL expression and its relative
contribution to positive selection is compatible with the
fact that mice with a polyclonal TCR repertoire also have
fewer FasL  thymocytes, especially at the DP stage (Fig. 2
B). This lower expression level is likely due to a much
lower efficiency of positive selection in polyclonal B6 com-
pared with TCR Tg mice, in which all thymocytes bear
TCRs capable of positive selection.
While we favor the unified model that avidity of the
TCR for its positively selecting ligand defines both the up-
per and lower limits for the influence of FasL-mediated co-
stimulation on thymocyte maturation (Fig. 7 C), there is an
alternative explanation for the H-Y phenotype. Perhaps the
aberrantly early expression of the H-Y TCR delivers a pos-
itive selection signal before the stage at which FasL-medi-
ated costimulation can be engaged, and thus bypasses the
influence of FasL observed in other strains.
Our data are compatible with the notion that Fas/FasL
interaction enhances the efficiency of thymocyte selection
for TCR:MHC/peptide complexes within a particular af-
finity window. The decrease in the number of mature thy-
mocytes, the aberrant expression of CD24, and the paucity
of DP TCRhi cells all suggest that the multi-step process of
positive selection is defective in the absence of functional
FasL. An alteration in signaling may be involved and is sug-
gested by the balance of TCR/CD5 levels observed in
AND I-Ab versus AND I-Ek mice.
The nature of the costimulatory signal delivered through
FasL is unknown, although the structure of FasL suggests
signaling capacity. Its highly conserved, proline-rich, cyto-
plasmic tail is distinct from that of other costimulatory mol-
ecules such as CD28 and LFA-1, and contains several SH3
consensus binding domains (48), a casein kinase I motif
(49), other putative interaction domains (50), and motifs
that target FasL to secretory vesicles (42). The Src-family
protein tyrosine kinase Fyn has been shown to bind to pep-
tides containing the FasL SH3 domains (48). Using chemi-
cal inducers of dimerization (51), our preliminary experi-
ments show that cocrosslinking the cytoplasmic tails of
CD3  and FasL in Jurkat T cells enhances IL-2 promoter
activity (unpublished data). While the undoubtedly com-
plex signaling pathways invoked during positive and nega-
tive selection have yet to be fully unraveled, it is clear that
structural motifs in the TCR can differentially affect posi-
tive and negative selection (52), and that qualitatively or
quantitatively distinct signaling pathways may also contrib-
ute (for a review, see reference 53). Add the bipolar mole-
cule FasL to this list of modulators and thymocyte matura-
tion deepens in complexity.
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